Patients with neurotrophic keratitis who underwent treatment with Oxervate in a real-world setting experienced favorable improvements in corneal sensation, visual acuity and stability of the corneal epithelium, according to a speaker at the virtual American Society of Cataract and Refractive Surgery meeting.
“There may also be a particular benefit in those patients with a preexisting persistent epithelial defect or who are BCL-dependent,” Amar P. Shah, MD, MBA, said.
Shah and colleagues conducted a retrospective chart review of 57 eyes of 53 patients treated with Oxervate
Uncategorized